SEC Tracker
Get the app

TELA Bio TELA

TELA Bio Bio gets FDA clearance for Liora product

Form
8-K
Filed
Importance
Routine
  1. Received 510(k) clearance for Liora Monofilament Scaffold
  2. Liora is fully resorbable surgical mesh
  3. First product developed in ISO 8 certified cleanroom
  4. Announced on October 5, 2026

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when TELA Bio files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. enVVeno Medical NVNO public float $76M, Jun 30, 2025
  2. Carlsmed CARL
  3. Apyx Medical APYX public float $80M, Jun 30, 2025
  4. Spectral AI MDAI public float $72M, Jun 30, 2025
  5. Lucid Diagnostics LUCD public float $83M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.